Hepatitis delta virus: From infection to new therapeutic strategies

doi:10.3748/wjg.v27.i24.3530

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 24

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8318)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

657

WORD

140

HTML

5799

Figures (1-1)

277

Tables (1-1)

208

Sum=7081

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

394

Download

843

Sum=1237

Jun 28, 2021 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Jun 28, 2021; 27(24): 3530-3542
Published online Jun 28, 2021. doi: 10.3748/wjg.v27.i24.3530

Open in New Tab Full Size Figure Download Figure

Figure 1 Schematic representation of the hepatitis D virus life cycle. New drugs interfere with the hepatitis B surface antigen at the viral entry or viral assembly level. HBsAg: Hepatitis B surface antigen; HDAg: Hepatitis D antigen; HDV: Hepatitis delta virus; L-HDAg: Large hepatitis D antigen; NTCP: Sodium tauro-cholate cotransporting polypeptide; RNP: Ribonucleoprotein complex; S-HDAg: Small hepatitis D antigen.

Citation: Niro GA, Ferro A, Cicerchia F, Brascugli I, Durazzo M. Hepatitis delta virus: From infection to new therapeutic strategies. World J Gastroenterol 2021; 27(24): 3530-3542
URL: https://www.wjgnet.com/1007-9327/full/v27/i24/3530.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i24.3530